Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Anna Gaulton
Affiliation
European Bioinformatics Institute (EMBL-EBI)
ORCID
Career Start Year
2002
Papers
51
H Index
27
Expertise
CM4AI Collaborator
Kirsten Obernier (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37933841
The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods.
Nucleic Acids Res
2024
37933841
The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods.
Nucleic Acids Res
2024
37069670
Biomedical data analyses facilitated by open cheminformatics workflows.
J Cheminform
2023
37151295
Illuminating the druggable genome through patent bioactivity data.
PeerJ
2023
37069670
Biomedical data analyses facilitated by open cheminformatics workflows.
J Cheminform
2023
37151295
Illuminating the druggable genome through patent bioactivity data.
PeerJ
2023
33983732
Target-Based Evaluation of "Drug-Like" Properties and Ligand Efficiencies.
J Med Chem
2021
33837377
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.
Nat Med
2021
33507738
Drug Safety Data Curation and Modeling in ChEMBL: Boxed Warnings and Withdrawn Drugs.
Chem Res Toxicol
2021
33983732
Target-Based Evaluation of "Drug-Like" Properties and Ligand Efficiencies.
J Med Chem
2021
33507738
Drug Safety Data Curation and Modeling in ChEMBL: Boxed Warnings and Withdrawn Drugs.
Chem Res Toxicol
2021
33837377
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.
Nat Med
2021
32645325
The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
Cell
2020
32645325
The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
Cell
2020
30398643
ChEMBL: towards direct deposition of bioassay data.
Nucleic Acids Res
2019
31827124
Improving the odds of drug development success through human genomics: modelling study.
Sci Rep
2019
33430932
Reply to "Missed opportunities in large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery".
J Cheminform
2019
30398643
ChEMBL: towards direct deposition of bioassay data.
Nucleic Acids Res
2019
30631996
Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery.
J Cheminform
2019
31827124
Improving the odds of drug development success through human genomics: modelling study.
Sci Rep
2019
33430932
Reply to "Missed opportunities in large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery".
J Cheminform
2019
30631996
Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery.
J Cheminform
2019
29567993
Unexplored therapeutic opportunities in the human genome.
Nat Rev Drug Discov
2018
30351302
A large-scale dataset of in vivo pharmacology assay results.
Sci Data
2018
29567993
Unexplored therapeutic opportunities in the human genome.
Nat Rev Drug Discov
2018
29472638
Unexplored therapeutic opportunities in the human genome.
Nat Rev Drug Discov
2018
30351302
A large-scale dataset of in vivo pharmacology assay results.
Sci Data
2018
29472638
Unexplored therapeutic opportunities in the human genome.
Nat Rev Drug Discov
2018
27899562
The ChEMBL database in 2017.
Nucleic Acids Res
2017
28602100
Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery.
Expert Opin Drug Discov
2017
28356508
The druggable genome and support for target identification and validation in drug development.
Sci Transl Med
2017
27899665
Open Targets: a platform for therapeutic target identification and validation.
Nucleic Acids Res
2017
27899562
The ChEMBL database in 2017.
Nucleic Acids Res
2017
27910877
A comprehensive map of molecular drug targets.
Nat Rev Drug Discov
2017
27903890
Pharos: Collating protein information to shed light on the druggable genome.
Nucleic Acids Res
2017
28356508
The druggable genome and support for target identification and validation in drug development.
Sci Transl Med
2017
28602100
Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery.
Expert Opin Drug Discov
2017
27910877
A comprehensive map of molecular drug targets.
Nat Rev Drug Discov
2017
27903890
Pharos: Collating protein information to shed light on the druggable genome.
Nucleic Acids Res
2017
27899665
Open Targets: a platform for therapeutic target identification and validation.
Nucleic Acids Res
2017
27678076
A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL.
J Biomed Semantics
2016
26582922
SureChEMBL: a large-scale, chemically annotated patent document database.
Nucleic Acids Res
2016
27678076
A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL.
J Biomed Semantics
2016
27774140
Open PHACTS computational protocols for <i>in silico</i> target validation of cellular phenotypic screens: knowing the knowns.
Medchemcomm
2016
26582922
SureChEMBL: a large-scale, chemically annotated patent document database.
Nucleic Acids Res
2016
27774140
Open PHACTS computational protocols for <i>in silico</i> target validation of cellular phenotypic screens: knowing the knowns.
Medchemcomm
2016
25313161
The complex portal--an encyclopaedia of macromolecular complexes.
Nucleic Acids Res
2015
25883136
ChEMBL web services: streamlining access to drug discovery data and utilities.
Nucleic Acids Res
2015
25313161
The complex portal--an encyclopaedia of macromolecular complexes.
Nucleic Acids Res
2015
25348214
PPDMs-a resource for mapping small molecule bioactivities from ChEMBL to Pfam-A protein domains.
Bioinformatics
2015
1 - 50 of 102
Column Actions
Search
Recommended Authors
Giovanni Bocci
The University of New Mexico School of Medicine
Career Start Year
2016
Number of shared co-authors
5
Wail Ba-Alawi
Princess Margaret Cancer Centre, University Health Network, University Ave.
Career Start Year
2013
Number of shared co-authors
2
Tunca Do??an
Hacettepe University
Career Start Year
2013
Number of shared co-authors
13
Bin Chen
Jiangsu University
Career Start Year
2009
Number of shared co-authors
2
Michael J Keiser
Institute for Neurodegenerative Diseases, University of California san francisco
Career Start Year
2007
Number of shared co-authors
5
Evan E Bolton
National Center for Biotechnology Information, National Institutes of Health
Career Start Year
2007
Number of shared co-authors
13
Ola Spjuth
Department of Pharmaceutical Biosciences, Uppsala University
Career Start Year
2006
Number of shared co-authors
10
Sanjay J Swamidass
Washington University School of Medicine
Career Start Year
2005
Number of shared co-authors
2
Anang A Shelat
St. Jude Children's Research Hospital
Career Start Year
2003
Number of shared co-authors
5
Egon L Willighagen
Maastricht University
Career Start Year
2003
Number of shared co-authors
20
Scott Boyer
Swedish Toxicology Sciences Research Center, Karolinska Institutet
Career Start Year
2002
Number of shared co-authors
5
John J Irwin
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year
2002
Number of shared co-authors
8
Gerald H Lushington
Inc. 16 Dekalb Pike
Career Start Year
2002
Number of shared co-authors
0
Montserrat Cases
Hospital del Mar Medical Research Institute (IMIM), Universitat Pompeu Fabra
Career Start Year
2001
Number of shared co-authors
5
Tommi H Nyr??nen
CSC - IT Center for Science Ltd
Career Start Year
1999
Number of shared co-authors
9
Paul A Clemons
Broad Institute
Career Start Year
1999
Number of shared co-authors
6
David Lagorce
INSERM
Career Start Year
1998
Number of shared co-authors
0
Patrick Aloy
Institucio Catalana de Recerca i Estudis Avancats (ICREA)
Career Start Year
1997
Number of shared co-authors
10
Vlado Dan????k
Broad Institute
Career Start Year
1997
Number of shared co-authors
1
Niklas Blomberg
Universitat Tubingen, Institut fur Arbeitsmedizin
Career Start Year
1996
Number of shared co-authors
25
Peter Kolb
Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg
Career Start Year
1996
Number of shared co-authors
2
S??ndor Szalma
Takeda California Inc.
Career Start Year
1995
Number of shared co-authors
1
Arya Ajay
National Center for Advancing Translational Science, 9800 Medical Center Drive
Career Start Year
1993
Number of shared co-authors
6
David J Wild
Indiana University Bloomington
Career Start Year
1992
Number of shared co-authors
8
Robert Preissner
Institute for Physiology, Charite-University Medicine Berlin
Career Start Year
1990
Number of shared co-authors
3
Michael S Lajiness
Lilly Research Laboratories
Career Start Year
1989
Number of shared co-authors
2
Russ B Altman
Stanford University
Career Start Year
1982
Number of shared co-authors
5
Ruben Abagyan
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year
1981
Number of shared co-authors
3
Christine Humblet
Lilly Research Laboratories
Career Start Year
1977
Number of shared co-authors
2
Stephen H Bryant
National Center for Biotechnology Information
Career Start Year
1973
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
John P Overington
Institute of Cardiovascular Science, University College London
Co-authored papers
24
Anne Hersey
Co-authored papers
23
Andrew R Leach
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers
14
George Papadatos
European Molecular Biology Laboratory - European Bioinformatics Institute
Co-authored papers
10
Teresa K Attwood
Co-authored papers
6
Eloy Felix
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers
6
Tudor I Oprea
Expert Systems Inc.
Co-authored papers
5
Anneli Karlsson
Co-authored papers
4
Henning Hermjakob
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers
4
Cristian G Bologa
University of New Mexico School of Medicine
Co-authored papers
4
Lee Harland
Connected Discovery Ltd
Co-authored papers
4
Bissan Al-Lazikani
The University of Texas MD Anderson Cancer Center
Co-authored papers
4
Oleg Ursu
Co-authored papers
4
Anna Waller
Co-authored papers
3
Stephen L Mathias
Co-authored papers
3
Larry A Sklar
Co-authored papers
3
Subramani Mani
Co-authored papers
3
Dušica VidoviĿ
Co-authored papers
3
Rajarshi Guha
Vertex Pharmaceuticals
Co-authored papers
3
Jeremy J Yang
Co-authored papers
3
Sameer Velankar
European Bioinformatics Institute
Co-authored papers
3
Noel Southall
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers
3
Juan P Casas
Co-authored papers
3
Sandra Orchard
EMBL's European Bioinformatics Institute (EMBL-EBI)
Co-authored papers
3
Ajit Jadhav
Co-authored papers
3
Jayme Holmes
Co-authored papers
3
Avi Ma'ayan
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Stephan C Sch??rer
Institute for Data Science and Computing, University of Miami
Co-authored papers
3
Dac-Trung Nguyen
Co-authored papers
3
S??ren Brunak
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers
3
1 - 30